HEADER TRANSFERASE 12-NOV-11 4A7C TITLE CRYSTAL STRUCTURE OF PIM1 KINASE WITH ETP46546 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE PIM-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 434-717; COMPND 5 SYNONYM: PIM1; COMPND 6 EC: 2.7.1.37, 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: PHOSPHORYLATED AT SER 261 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA PLYSS KEYWDS TRANSFERASE, PROTEIN KINASE, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR M.MAZZORANA,G.MONTOYA REVDAT 3 14-JAN-15 4A7C 1 HETNAM REVDAT 2 23-MAY-12 4A7C 1 REMARK DBREF REVDAT 1 15-FEB-12 4A7C 0 JRNL AUTH J.PASTOR,J.OYARZABAL,G.SALUSTE,R.M.ALVAREZ,V.RIVERO,F.RAMOS, JRNL AUTH 2 E.CENDON,C.BLANCO-APARICIO,N.AJENJO,A.CEBRIA,M.I.ALBARRAN, JRNL AUTH 3 D.CEBRIAN,A.CORRIONERO,J.FOMINAYA,G.MONTOYA,M.MAZZORANA JRNL TITL HIT TO LEAD EVALUATION OF 1,2,3-TRIAZOLO[4,5-B]PYRIDINES AS JRNL TITL 2 PIM KINASE INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 1591 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22266039 JRNL DOI 10.1016/J.BMCL.2011.12.130 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.300 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.678 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.04 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.98 REMARK 3 NUMBER OF REFLECTIONS : 19934 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.1709 REMARK 3 R VALUE (WORKING SET) : 0.1689 REMARK 3 FREE R VALUE : 0.2072 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 1015 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.6891 - 4.3989 0.99 2796 145 0.1554 0.1883 REMARK 3 2 4.3989 - 3.4918 1.00 2777 135 0.1458 0.1723 REMARK 3 3 3.4918 - 3.0505 0.99 2720 144 0.1668 0.1980 REMARK 3 4 3.0505 - 2.7716 0.99 2696 152 0.1787 0.2333 REMARK 3 5 2.7716 - 2.5730 0.97 2656 152 0.1878 0.2481 REMARK 3 6 2.5730 - 2.4213 0.97 2654 142 0.1875 0.2204 REMARK 3 7 2.4213 - 2.3000 0.95 2620 145 0.1972 0.2546 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.335 REMARK 3 B_SOL : 29.444 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.24 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.64 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.9 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.0270 REMARK 3 B22 (A**2) : 1.0270 REMARK 3 B33 (A**2) : -2.0541 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : 0.0000 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2331 REMARK 3 ANGLE : 1.134 3166 REMARK 3 CHIRALITY : 0.071 334 REMARK 3 PLANARITY : 0.004 409 REMARK 3 DIHEDRAL : 18.668 849 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: DISORDERED N-TERMINUS AND PART OF REMARK 3 GLU 32 REMARK 4 REMARK 4 4A7C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-NOV-11. REMARK 100 THE PDBE ID CODE IS EBI-50272. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD (MX-225) REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20344 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.30 REMARK 200 RESOLUTION RANGE LOW (A) : 49.68 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.6 REMARK 200 R MERGE (I) : 0.10 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.80 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.6 REMARK 200 R MERGE FOR SHELL (I) : 0.44 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1YXT REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M IMIDAZOLE PH 7.0, 1 M REMARK 280 NA ACETATE. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.07933 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.03967 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.55950 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 13.51983 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 67.59917 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 SER A 9 REMARK 465 HIS A 10 REMARK 465 HIS A 11 REMARK 465 HIS A 12 REMARK 465 HIS A 13 REMARK 465 HIS A 14 REMARK 465 HIS A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 GLY A 18 REMARK 465 LEU A 19 REMARK 465 GLU A 20 REMARK 465 VAL A 21 REMARK 465 LEU A 22 REMARK 465 PHE A 23 REMARK 465 GLN A 24 REMARK 465 GLY A 25 REMARK 465 PRO A 26 REMARK 465 HIS A 27 REMARK 465 MET A 28 REMARK 465 LYS A 29 REMARK 465 GLU A 30 REMARK 465 LYS A 31 REMARK 465 SER A 306 REMARK 465 LEU A 307 REMARK 465 SER A 308 REMARK 465 PRO A 309 REMARK 465 GLY A 310 REMARK 465 PRO A 311 REMARK 465 SER A 312 REMARK 465 LYS A 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 32 CG CD OE1 OE2 REMARK 470 SER A 46 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 59 -71.03 -51.97 REMARK 500 ASN A 82 -168.64 -77.91 REMARK 500 SER A 101 -173.62 -173.97 REMARK 500 ASP A 167 43.84 -143.31 REMARK 500 ASP A 186 79.73 66.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE E46 A1306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A1307 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A1308 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BIK RELATED DB: PDB REMARK 900 HUMAN PIM1 PHOSPHORYLATED ON SER261 REMARK 900 RELATED ID: 2XIX RELATED DB: PDB REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-1 FROM REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN REMARK 900 RELATED ID: 1YWV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF PROTO-ONCOGENE KINASE PIM1: A REMARK 900 TARGETOF ABERRANT SOMATIC HYPERMUTATIONS IN DIFFUSE LARGE REMARK 900 CELLLYMPHOMA REMARK 900 RELATED ID: 2BZJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH REMARK 900 A RUTHENIUM ORGANOMETALLIC LIGAND RU3 REMARK 900 RELATED ID: 2C3I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH REMARK 900 IMIDAZOPYRIDAZIN I REMARK 900 RELATED ID: 1YXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH AMP REMARK 900 RELATED ID: 2J2I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAB PIM1 IN COMPLEX WITH REMARK 900 LY333531 REMARK 900 RELATED ID: 1YXT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH REMARK 900 AMPPNP REMARK 900 RELATED ID: 2BZH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH REMARK 900 A RUTHENIUM ORGANOMETALLIC LIGAND RU1 REMARK 900 RELATED ID: 1YXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 WITH P123M MUTATION REMARK 900 RELATED ID: 1XQZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HPIM-1 KINASE AT 2.1 A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1YI3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PIM-1 BOUND TO LY294002 REMARK 900 RELATED ID: 2XIZ RELATED DB: PDB REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-3 FROM REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN REMARK 900 RELATED ID: 1YXV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH 3,4 REMARK 900 -DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE REMARK 900 RELATED ID: 1XR1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HPIM-1 KINASE IN COMPLEX WITH REMARK 900 AMP-PNPAT 2.1 A RESOLUTION REMARK 900 RELATED ID: 2XIY RELATED DB: PDB REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-2 FROM REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN REMARK 900 RELATED ID: 2BIL RELATED DB: PDB REMARK 900 THE HUMAN PROTEIN KINASE PIM1 IN COMPLEX WITH ITS REMARK 900 CONSENSUS PEPTIDE PIMTIDE REMARK 900 RELATED ID: 1YHS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PIM-1 BOUND TO STAUROSPORINE REMARK 900 RELATED ID: 1YXX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE PIM1 IN COMPLEX WITH (3E REMARK 900 )-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONE REMARK 900 RELATED ID: 1XWS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 KINASE DOMAIN REMARK 900 RELATED ID: 2XJ1 RELATED DB: PDB REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE REMARK 900 INIBITOR REMARK 900 RELATED ID: 2BZK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH REMARK 900 AMPPNP AND PIMTIDE REMARK 900 RELATED ID: 2XJ0 RELATED DB: PDB REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-4 FROM REMARK 900 CRYSTALLOGRAPHIC FRAGMENT SCREEN REMARK 900 RELATED ID: 2XJ2 RELATED DB: PDB REMARK 900 PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 1YI4 RELATED DB: PDB REMARK 900 STRUCTURE OF PIM-1 BOUND TO ADENOSINE REMARK 900 RELATED ID: 2BZI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH REMARK 900 A RUTHENIUM ORGANOMETALLIC LIGAND RU2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 GENE ACCORDING TO ORIGENE ACCESSION NUMBER NM_002648 REMARK 999 UNIPROT ISOFORM 2 DBREF 4A7C A 30 313 UNP P11309 PIM1_HUMAN 30 313 SEQADV 4A7C MET A 6 UNP P11309 EXPRESSION TAG SEQADV 4A7C GLY A 7 UNP P11309 EXPRESSION TAG SEQADV 4A7C SER A 8 UNP P11309 EXPRESSION TAG SEQADV 4A7C SER A 9 UNP P11309 EXPRESSION TAG SEQADV 4A7C HIS A 10 UNP P11309 EXPRESSION TAG SEQADV 4A7C HIS A 11 UNP P11309 EXPRESSION TAG SEQADV 4A7C HIS A 12 UNP P11309 EXPRESSION TAG SEQADV 4A7C HIS A 13 UNP P11309 EXPRESSION TAG SEQADV 4A7C HIS A 14 UNP P11309 EXPRESSION TAG SEQADV 4A7C HIS A 15 UNP P11309 EXPRESSION TAG SEQADV 4A7C SER A 16 UNP P11309 EXPRESSION TAG SEQADV 4A7C SER A 17 UNP P11309 EXPRESSION TAG SEQADV 4A7C GLY A 18 UNP P11309 EXPRESSION TAG SEQADV 4A7C LEU A 19 UNP P11309 EXPRESSION TAG SEQADV 4A7C GLU A 20 UNP P11309 EXPRESSION TAG SEQADV 4A7C VAL A 21 UNP P11309 EXPRESSION TAG SEQADV 4A7C LEU A 22 UNP P11309 EXPRESSION TAG SEQADV 4A7C PHE A 23 UNP P11309 EXPRESSION TAG SEQADV 4A7C GLN A 24 UNP P11309 EXPRESSION TAG SEQADV 4A7C GLY A 25 UNP P11309 EXPRESSION TAG SEQADV 4A7C PRO A 26 UNP P11309 EXPRESSION TAG SEQADV 4A7C HIS A 27 UNP P11309 EXPRESSION TAG SEQADV 4A7C MET A 28 UNP P11309 EXPRESSION TAG SEQADV 4A7C LYS A 29 UNP P11309 EXPRESSION TAG SEQRES 1 A 308 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 308 LEU GLU VAL LEU PHE GLN GLY PRO HIS MET LYS GLU LYS SEQRES 3 A 308 GLU PRO LEU GLU SER GLN TYR GLN VAL GLY PRO LEU LEU SEQRES 4 A 308 GLY SER GLY GLY PHE GLY SER VAL TYR SER GLY ILE ARG SEQRES 5 A 308 VAL SER ASP ASN LEU PRO VAL ALA ILE LYS HIS VAL GLU SEQRES 6 A 308 LYS ASP ARG ILE SER ASP TRP GLY GLU LEU PRO ASN GLY SEQRES 7 A 308 THR ARG VAL PRO MET GLU VAL VAL LEU LEU LYS LYS VAL SEQRES 8 A 308 SER SER GLY PHE SER GLY VAL ILE ARG LEU LEU ASP TRP SEQRES 9 A 308 PHE GLU ARG PRO ASP SER PHE VAL LEU ILE LEU GLU ARG SEQRES 10 A 308 PRO GLU PRO VAL GLN ASP LEU PHE ASP PHE ILE THR GLU SEQRES 11 A 308 ARG GLY ALA LEU GLN GLU GLU LEU ALA ARG SER PHE PHE SEQRES 12 A 308 TRP GLN VAL LEU GLU ALA VAL ARG HIS CYS HIS ASN CYS SEQRES 13 A 308 GLY VAL LEU HIS ARG ASP ILE LYS ASP GLU ASN ILE LEU SEQRES 14 A 308 ILE ASP LEU ASN ARG GLY GLU LEU LYS LEU ILE ASP PHE SEQRES 15 A 308 GLY SER GLY ALA LEU LEU LYS ASP THR VAL TYR THR ASP SEQRES 16 A 308 PHE ASP GLY THR ARG VAL TYR SER PRO PRO GLU TRP ILE SEQRES 17 A 308 ARG TYR HIS ARG TYR HIS GLY ARG SER ALA ALA VAL TRP SEQRES 18 A 308 SER LEU GLY ILE LEU LEU TYR ASP MET VAL CYS GLY ASP SEQRES 19 A 308 ILE PRO PHE GLU HIS ASP GLU GLU ILE ILE ARG GLY GLN SEQRES 20 A 308 VAL PHE PHE ARG GLN ARG VAL SER SEP GLU CYS GLN HIS SEQRES 21 A 308 LEU ILE ARG TRP CYS LEU ALA LEU ARG PRO SER ASP ARG SEQRES 22 A 308 PRO THR PHE GLU GLU ILE GLN ASN HIS PRO TRP MET GLN SEQRES 23 A 308 ASP VAL LEU LEU PRO GLN GLU THR ALA GLU ILE HIS LEU SEQRES 24 A 308 HIS SER LEU SER PRO GLY PRO SER LYS MODRES 4A7C SEP A 261 SER PHOSPHOSERINE HET SEP A 261 10 HET E46 A1306 28 HET IMD A1307 5 HET ACT A1308 4 HETNAM SEP PHOSPHOSERINE HETNAM E46 N-(PIPERIDIN-4-YLMETHYL)-3-[3-(TRIFLUOROMETHYLOXY) HETNAM 2 E46 PHENYL]-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE HETNAM IMD IMIDAZOLE HETNAM ACT ACETATE ION HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP C3 H8 N O6 P FORMUL 3 E46 C18 H19 F3 N6 O FORMUL 4 IMD C3 H5 N2 1+ FORMUL 5 ACT C2 H3 O2 1- FORMUL 6 HOH *190(H2 O) HELIX 1 1 GLU A 32 GLN A 37 1 6 HELIX 2 2 ASP A 72 ILE A 74 5 3 HELIX 3 3 MET A 88 SER A 97 1 10 HELIX 4 4 LEU A 129 GLY A 137 1 9 HELIX 5 5 GLN A 140 CYS A 161 1 22 HELIX 6 6 LYS A 169 GLU A 171 5 3 HELIX 7 7 THR A 204 SER A 208 5 5 HELIX 8 8 PRO A 209 HIS A 216 1 8 HELIX 9 9 HIS A 219 GLY A 238 1 20 HELIX 10 10 HIS A 244 GLY A 251 1 8 HELIX 11 11 SER A 260 LEU A 271 1 12 HELIX 12 12 ARG A 274 ARG A 278 5 5 HELIX 13 13 THR A 280 ASN A 286 1 7 HELIX 14 14 HIS A 287 GLN A 291 5 5 HELIX 15 15 LEU A 295 LEU A 304 1 10 SHEET 1 AA 5 TYR A 38 GLY A 47 0 SHEET 2 AA 5 GLY A 50 ARG A 57 -1 O GLY A 50 N GLY A 47 SHEET 3 AA 5 PRO A 63 GLU A 70 -1 O VAL A 64 N GLY A 55 SHEET 4 AA 5 SER A 115 GLU A 121 -1 O PHE A 116 N VAL A 69 SHEET 5 AA 5 LEU A 106 GLU A 111 -1 N LEU A 107 O ILE A 119 SHEET 1 AB 2 TRP A 77 GLU A 79 0 SHEET 2 AB 2 ARG A 85 PRO A 87 -1 O VAL A 86 N GLY A 78 SHEET 1 AC 3 VAL A 126 ASP A 128 0 SHEET 2 AC 3 ILE A 173 ASP A 176 -1 N ILE A 175 O GLN A 127 SHEET 3 AC 3 GLU A 181 LEU A 184 -1 O GLU A 181 N ASP A 176 SHEET 1 AD 2 VAL A 163 LEU A 164 0 SHEET 2 AD 2 ALA A 191 LEU A 192 -1 O ALA A 191 N LEU A 164 LINK N SEP A 261 C SER A 260 1555 1555 1.33 LINK C SEP A 261 N GLU A 262 1555 1555 1.33 CISPEP 1 GLU A 124 PRO A 125 0 -0.98 SITE 1 AC1 11 LEU A 44 PHE A 49 ALA A 65 LYS A 67 SITE 2 AC1 11 GLU A 121 ASP A 128 GLU A 171 LEU A 174 SITE 3 AC1 11 ASP A 186 HOH A2012 HOH A2106 SITE 1 AC2 6 PHE A 130 THR A 134 ASP A 170 ASP A 234 SITE 2 AC2 6 GLY A 238 ASP A 239 SITE 1 AC3 5 HIS A 219 ARG A 221 SER A 222 HOH A2139 SITE 2 AC3 5 HOH A2175 CRYST1 99.355 99.355 81.119 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010065 0.005811 0.000000 0.00000 SCALE2 0.000000 0.011622 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012328 0.00000 MASTER 366 0 4 15 12 0 7 6 0 0 0 24 END